Total Clarity Wealth Management, Inc. Tyme Technologies, Inc. Transaction History

Total Clarity Wealth Management, Inc.

  • $282 Million
  • Q2 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 29, 2022
SELL
$0.28 - $0.68 $252 - $612
-900 Closed
0 $0
Q3 2021

Oct 21, 2021
BUY
$0.99 - $1.38 $891 - $1,242
900 New
900 $1,000
Q2 2021

Jul 26, 2021
SELL
$1.14 - $1.87 $1,026 - $1,683
-900 Closed
0 $0
Q1 2021

May 05, 2021
BUY
$1.34 - $3.53 $1,206 - $3,177
900 New
900 $2,000
Q1 2020

Apr 24, 2020
SELL
$0.9 - $1.95 $810 - $1,755
-900 Closed
0 $0
Q4 2019

Feb 27, 2020
BUY
$1.0 - $1.49 $900 - $1,341
900 New
900 $1,000

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Total Clarity Wealth Management, Inc. Portfolio

Follow Total Clarity Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email